- Aminoglycoside Antibacterials
- Accession Number
- DBCAT000853 (DBCAT002397)
A category of amino glycoside antibacterials. Must have an amino group attached to a glycoside and have antibacterial effects. Relation to Streptomyces spp. is considered important, but is not enough alone to allow for categorization here. Structurally, it must be an aminoglycoside. It must have antibacterial properties. It potentially came from a Streptomycin spp.
- ATC Classification
Drug Drug Description Amikacin An aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria. Tobramycin An aminoglycoside antibiotic used to treat cystic fibrosis, lung infections, eye infections, and a variety of other infections. Gentamicin An aminoglycoside used to treat a wide variety of infections in the body. Neomycin An aminoglycoside antibiotic agent used orally and topically to treat a wide variety of infections in the body. Streptomycin An aminoglycoside antibiotic indicated to treat mycobacterium tuberculosis and various non-tuberculosis infections. Framycetin An aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus. Netilmicin An aminoglycoside used to treat a wide variety of infections in the body. Kanamycin An aminoglycoside antibiotic agent used in the treatment of various infections caused by susceptible bacteria. Paromomycin An aminoglycoside antibiotic used in the treatment of acute and chronic intestinal amebiasis, and as an adjunct for the management of hepatic coma. Ribostamycin A broad spectrum aminoglycoside antibiotic on the list of WHO critical antimicrobials for human medicine. Geneticin Geneticin (also known as G418) is an aminoglycoside antibiotic similar in structure to gentamicin B1, produced by Micromonospora rhodorangea. Geneticin blocks polypeptide synthesis by inhibiting the elongation step in both... Apramycin For the treatment of bacterial infections in animals. Gentamicin C1a Not Available Neamine Not Available Arbekacin Arbekacin is used for the short term treatment of multi-resistant bacterial infections, such as methicillin-resistant Staphylococcus aureus (MRSA). Puromycin Puromycin is an antibiotic that prevents bacterial protein translation. It is utilized as a selective agent in laboratory cell cultures. Puromycin is toxic to both prokaryotic and eukaryotic cells, resulting... Dihydrostreptomycin Dihydrostreptomycin is an antibiotic. Hygromycin B Hygromycin B is an aminoglycoside antibiotic produced by the bacterium Streptomyces hygroscopicus which kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis. Sisomicin Sisomicin has been used in trials studying the treatment of Pyoderma. Plazomicin An aminoglycoside antibiotic used to treat complicated urinary tract infections. Dibekacin Dibekacin is an aminoglycoside antibiotic marketed in Japan . Micronomicin Micronomicin is an aminoglycoside antibiotic which is marketed in Japan, and sold under the brand names Sagamicin and Luxomicina. Isepamicin Not Annotated Bekanamycin Not Annotated Capreomycin An aminoglycoside antibiotic used as an adjunct drug in tuberculosis. Colistin A polymyxin antibiotic used to treat bacterial infections caused by susceptible Gram negative bacteria.
- Drugs & Drug Targets